This company listing is no longer active
BBS-Bioactive Bone Substitutes Oyj Balance Sheet Health
Financial Health criteria checks 4/6
BBS-Bioactive Bone Substitutes Oyj has a total shareholder equity of €4.3M and total debt of €5.7M, which brings its debt-to-equity ratio to 132.8%. Its total assets and total liabilities are €10.7M and €6.4M respectively.
Key information
132.8%
Debt to equity ratio
€5.67m
Debt
| Interest coverage ratio | n/a |
| Cash | €1.52m |
| Equity | €4.27m |
| Total liabilities | €6.42m |
| Total assets | €10.69m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BONEHU0123's short term assets (€1.9M) exceed its short term liabilities (€1.7M).
Long Term Liabilities: BONEHU0123's short term assets (€1.9M) do not cover its long term liabilities (€4.7M).
Debt to Equity History and Analysis
Debt Level: BONEHU0123's net debt to equity ratio (97.3%) is considered high.
Reducing Debt: BONEHU0123's debt to equity ratio has reduced from 1598.9% to 132.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: BONEHU0123 has sufficient cash runway for 6 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: BONEHU0123 is forecast to have sufficient cash runway for 6 months based on free cash flow estimates, but has since raised additional capital.